TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
TerminatedN/A

tDCS in Parkinson's Disease With Depression

Parkinson's disease (PD) is a progressive neurological disease that has effects on both movement and mental health. One of the most common mental health complications of PD is depression.

Vancouver, British Columbia, CanadaView details
Recruiting

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

To develop a model to predict disease progression in a large cohort of patients across a variety of neurodegenerative diseases, including Mild Cognitive Impairment (MCI) and dementia due to any neurodegenerative disease, including Alzheimer

North York, Ontario, Canada+3 moreView details
Completed

Diagnosis and Natural History Study of Patients With Neurological Conditions

The purpose of this study is to improve understanding of neurological conditions. Patients participating in this study will continue receiving medical care, routine laboratory tests, and diagnostics tests (X-rays, CT-scans, and nuclear imag

Bethesda, Maryland, United StatesView details
CompletedPhase 2 / Phase 3

A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants

The purpose of this study is to evaluate the efficacy and safety of TVP-1012 (0.5 mg or 1 mg/day) as an add-on to levodopa in Japanese participants with Parkinson's disease with wearing-off phenomenon.

Nagoya, Aichi-ken, Japan+56 moreView details
Completed

Measures of Motor Impairment in Early Parkinson's Disease

This study will test the accuracy of a new home-use electronic device that measures and records small changes in Parkinson's disease symptoms, such as tremor and impaired movement and speech. The testing is done at home and the results are

Bethesda, Maryland, United StatesView details
Active, not recruitingPhase 1 / Phase 2

Repurposing Lithium for Parkinson's Disease: a RCT

This study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.

Williamsville, New York, United StatesView details
RecruitingEARLY_Phase 1

Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)

In this pilot study the research will explore whether exercises and the outcome measures would be acceptable to conduct a more detailed research study. This 8 week pilot study will utilize a comprehensive exercise program that includes non-

Ventura, California, United StatesView details
UnknownN/A

Caregiving in Advanced PD: A Tailored Support Group

The goal of this study is to understand how support groups can help people who care for individuals with Parkinson's Disease and Related Disorders (PDRD). The investigators want to find answers to these questions: * How do these support gr

Calgary, Alberta, CanadaView details
CompletedPhase 2

A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying

Gastric emptying is the end-result of a complex and carefully regulated series of events which follow the ingestion of a meal, each of which is dependent on the other and subject to neurohormonal control. Motilin is an endogenous peptide, p

Randwick, New South Wales, Australia+10 moreView details
CompletedN/A

teleRehabilitation for pAtients With ParkInson's Disease at Any mOment

The goal of this clinical trial is to test the feasibility and safety of a telerehabilitation and telemonitoring approach in people with Parkinson's disease at any stage. The main questions it aims to answer are: will patients with Parkinso

Ancona, Italy+1 moreView details
Completed

A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkinson's Disease

The aim of this research program is to develop and validate a smartphone app-based digital measurement concept that: * Objectively quantifies the severity of Parkinson's Disease (PD) related vocal and speech symptoms; * Accurately and sens

Chicago, Illinois, United StatesView details
TerminatedN/A

EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease

Study Purpose: Parkinson's disease leads to severally impaired motor control. The purpose of this study is to better understand and analyze the characteristics of arm muscle activity while doing some reaching tasks and of leg muscles while

Boston, Massachusetts, United StatesView details
Withdrawn

Attentional Performance in Parkinson Disease

Background: Parkinson Disease (PD) is a nervous system disorder that affects movement. Dopamine is an important neurotransmitter in the brain.

Bethesda, Maryland, United StatesView details
RecruitingPhase 1

This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.

This is a phase 1 clinical study to evaluate the safety, tolerability, feasibility, and preliminary efficacy of NouvNeu001 in patients with advanced Parkinson's Disease.

New York, New York, United StatesView details
CompletedN/A

Telephone-Based Counseling for Depression in Parkinson's Disease

There is a critical need for treatments that address depression and barriers to mental health care in Parkinson's disease (PD). This randomized-controlled trial will evaluate a 10-session telephone-guided cognitive behavioral self-help prog

Piscataway, New Jersey, United StatesView details
CompletedPhase 2

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

This is a study where AZD3241 or placebo is given to patients with Parkinson's disease in a blinded and randomized assignment. The main objective is to see if safety and tolerability of the drug is acceptable.

Birmingham, Alabama, United States+12 moreView details
TerminatedN/A

Sensor-supported Classification of Gait Patterns in Everyday Movement of Patients With Parkinson's Disease

Within this study we conduct long-term measurements on Parkinson patients using a three sensor IMU setup: one sensor is located at the wrist, one sensor at the belt/ in the pocket and one sensor is worn as a pendant. Before and after each l

Aachen, North Rhine-Westphalia, GermanyView details
RecruitingN/A

Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease

This study evaluates the clinical effect and safety of acupuncture combined with moxibustion in improving motor symptoms of early-stage Parkinson's Disease (PD) patients, by assessing the changes in UPDRS scores. It also explores objective

Beijing, Beijing Municipality, ChinaView details
Completed

Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease

The primary objective of this study is to evaluate the perception of pain associated with Parkinson´s Disease in patients who receive Neupro® for the first time.

Feldbach, Austria+26 moreView details
RecruitingPhase 1 / Phase 2

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

The Goal of this study is to evaluate the safety, tolerability, and clinical responses following implantation of DSP-1083. Study enrolls both male and female patients in 2 cohorts.

Lexington, Kentucky, United States+1 moreView details
Load more trials